Hospital
County of San Joaquin
County of San Joaquin was paid $48.27M by Medicaid between Jan 2018 and Dec 2024, across 390 billing codes. Its largest line is 0450, Emergency room services — 9.5% of everything it billed.
33Billing provider infoCOUNTY OF SAN JOAQUIN
FRENCH CAMP, CA 95231
FRENCH CAMP, CA 95231
33aNPI1952476525assigned 11/21/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$48.27M
24GClaims1,442,634
24DCodes billed390
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#64 of 410
Median peer was paid$6.90M
This provider vs. median7.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 269,624 | $6.93M | |
| 2019 | 260,848 | $7.76M | |
| 2020 | 197,007 | $6.93M | |
| 2021 | 201,637 | $6.85M | |
| 2022 | 226,750 | $8.62M | |
| 2023 | 218,153 | $8.62M | |
| 2024incomplete | 68,615 | $2.55M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 9.5% | 99,245 | 87,785 | $4.60M |
| 0682 | 8.2% | 1,113 | 1,110 | $3.94M | |
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 5.4% | 21,665 | 1,817 | $2.58M |
| 0510 | 3.9% | 61,701 | 53,078 | $1.89M | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.7% | 7,428 | 7,172 | $1.79M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.1% | 17,106 | 14,982 | $1.47M |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 2.4% | 5,498 | 1,485 | $1.17M |
| Z7502 | 2.4% | 32,605 | 32,070 | $1.16M | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.0% | 10,225 | 9,135 | $987K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.0% | 12,164 | 11,272 | $985K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.8% | 12,815 | 12,441 | $870K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.6% | 7,703 | 7,218 | $794K |
378 more codes
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.6% | 7,701 | $762K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 8,893 | $739K |
| 80053 | Comprehensive metabolic panel | 1.4% | 71,048 | $696K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.4% | 24,737 | $696K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 11,659 | $684K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 28,272 | $665K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 79,522 | $586K |
| 0761 | 1.1% | 19,816 | $537K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.1% | 13,323 | $509K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.0% | 3,921 | $506K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.0% | 3,187 | $497K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12,289 | $482K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 9,847 | $477K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 2,609 | $475K |
| 0250 | <1% | 65,028 | $433K | |
| 0683 | <1% | 691 | $412K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 9,698 | $396K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 8,494 | $371K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 11,111 | $347K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 17,301 | $338K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,550 | $335K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 7,161 | $324K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 3,891 | $311K |
| 71045 | Radiologic examination, chest; single view | <1% | 26,155 | $310K |
| J3490 | Unclassified drugs | <1% | 30,553 | $300K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,886 | $299K |
| Z7500 | <1% | 8,886 | $291K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 10,066 | $281K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 4,752 | $272K |
| Z9725 | <1% | 6,324 | $272K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 5,318 | $269K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,141 | $268K |
| 83880 | <1% | 7,404 | $259K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,324 | $254K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 3,097 | $252K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 4,464 | $232K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 4,321 | $230K |
| 0360 | <1% | 3,337 | $229K | |
| 84484 | <1% | 18,169 | $201K | |
| 70486 | <1% | 1,773 | $197K | |
| 76830 | Ultrasound, transvaginal | <1% | 3,105 | $188K |
| 71250 | <1% | 1,378 | $180K | |
| 70498 | <1% | 834 | $178K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,920 | $178K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 4,559 | $174K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 924 | $167K |
| Z7610 | <1% | 18,325 | $165K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 5,775 | $165K |
| 0160 | <1% | 481 | $164K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,100 | $163K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 21,047 | $163K |
| 92557 | <1% | 2,036 | $160K | |
| 76801 | <1% | 2,464 | $151K | |
| 0760 | <1% | 6,821 | $147K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 598 | $144K |
| 93971 | <1% | 1,439 | $144K | |
| 93970 | <1% | 855 | $138K | |
| 70496 | <1% | 635 | $134K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13,166 | $125K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 10,525 | $125K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 9,074 | $120K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,542 | $116K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 358 | $115K |
| 81001 | <1% | 35,881 | $115K | |
| 73610 | <1% | 5,224 | $109K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 1,587 | $108K |
| 0762 | <1% | 519 | $107K | |
| 73130 | <1% | 5,295 | $106K | |
| 84702 | <1% | 7,397 | $102K | |
| 86141 | <1% | 7,871 | $100K | |
| 90715 | <1% | 2,211 | $100K | |
| 83690 | <1% | 13,591 | $99K | |
| 87634 | <1% | 1,204 | $99K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,508 | $97K |
| 73110 | <1% | 4,487 | $95K | |
| 78451 | <1% | 723 | $94K | |
| 73630 | <1% | 4,545 | $92K | |
| 87088 | <1% | 14,240 | $92K | |
| 76770 | <1% | 1,399 | $91K | |
| 76641 | <1% | 1,241 | $90K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,027 | $87K |
| 83605 | <1% | 6,687 | $83K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 395 | $81K |
| 87040 | <1% | 4,385 | $81K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,315 | $80K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,209 | $78K |
| Z6006 | <1% | 2,490 | $78K | |
| 72170 | <1% | 3,867 | $77K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,037 | $77K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,008 | $76K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,079 | $74K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,965 | $74K |
| 73030 | <1% | 3,301 | $67K | |
| 94729 | <1% | 1,352 | $67K | |
| 90378 | <1% | 39 | $66K | |
| 73560 | <1% | 4,448 | $66K | |
| 83735 | <1% | 9,910 | $65K | |
| 72131 | <1% | 456 | $63K | |
| 85610 | <1% | 17,145 | $62K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,874 | $61K |
| 92588 | <1% | 1,034 | $61K | |
| 94726 | <1% | 1,333 | $61K | |
| 72141 | <1% | 299 | $59K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,645 | $59K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,134 | $58K |
| 84145 | <1% | 2,099 | $58K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 814 | $54K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 796 | $53K |
| 92587 | <1% | 1,078 | $51K | |
| 85730 | <1% | 8,660 | $51K | |
| 74018 | <1% | 2,399 | $51K | |
| 0710 | <1% | 2,164 | $50K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,603 | $49K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 628 | $49K |
| 72100 | <1% | 1,905 | $48K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,196 | $48K |
| 0361 | <1% | 368 | $47K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,339 | $46K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 1,542 | $45K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,167 | $45K |
| 94060 | <1% | 1,232 | $44K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,843 | $44K |
| 73590 | <1% | 2,494 | $44K | |
| 81025 | <1% | 12,280 | $44K | |
| 87070 | <1% | 5,141 | $43K | |
| 92550 | <1% | 1,919 | $43K | |
| 82948 | <1% | 8,891 | $43K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 257 | $43K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,461 | $42K |
| 73502 | <1% | 1,276 | $42K | |
| 73562 | <1% | 2,082 | $40K | |
| 73070 | <1% | 2,250 | $40K | |
| 99243 | <1% | 493 | $38K | |
| 73090 | <1% | 1,831 | $36K | |
| 86481 | <1% | 616 | $34K | |
| 95811 | <1% | 162 | $34K | |
| 72040 | <1% | 1,391 | $34K | |
| 96367 | <1% | 677 | $34K | |
| 86780 | <1% | 2,906 | $33K | |
| 0700 | <1% | 769 | $31K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,552 | $31K |
| 87077 | <1% | 3,616 | $29K | |
| 87186 | <1% | 3,443 | $29K | |
| 93000 | <1% | 661 | $29K | |
| 0750 | <1% | 250 | $29K | |
| 76536 | <1% | 537 | $28K | |
| 86703 | <1% | 4,429 | $27K | |
| 80061 | Lipid panel | <1% | 9,350 | $26K |
| 59025 | Fetal non-stress test | <1% | 1,665 | $26K |
| 84439 | <1% | 5,402 | $25K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 408 | $25K |
| 80143 | <1% | 1,207 | $25K | |
| 73552 | <1% | 1,007 | $25K | |
| 96415 | <1% | 549 | $24K | |
| 82728 | <1% | 3,144 | $24K | |
| 0270 | <1% | 1,689 | $24K | |
| 86803 | <1% | 3,959 | $23K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,283 | $23K |
| 73140 | <1% | 1,475 | $22K | |
| 85379 | <1% | 1,963 | $21K | |
| 86850 | <1% | 5,926 | $21K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,210 | $20K |
| J0636 | Injection, calcitriol, 0.1 mcg | <1% | 1,760 | $19K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 641 | $19K |
| 99205 | Prolong outpt/office vis | <1% | 168 | $18K |
| 86901 | <1% | 6,030 | $18K | |
| 73221 | <1% | 91 | $18K | |
| 0272 | <1% | 820 | $18K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 138 | $18K |
| 86900 | <1% | 6,036 | $18K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,849 | $17K |
| 97750 | <1% | 394 | $17K | |
| 77066 | Tomosynthesis, mammo | <1% | 130 | $17K |
| 90686 | <1% | 822 | $17K | |
| 76870 | <1% | 406 | $16K | |
| 96368 | <1% | 622 | $16K | |
| 99284 | Emergency room visit (serious) | <1% | 684 | $16K |
| 82550 | <1% | 2,488 | $16K | |
| 93271 | <1% | 214 | $16K | |
| 87340 | <1% | 3,619 | $15K | |
| 85651 | <1% | 5,791 | $15K | |
| 86480 | <1% | 480 | $15K | |
| 92570 | <1% | 491 | $14K | |
| 73060 | <1% | 715 | $14K | |
| 80069 | <1% | 3,207 | $14K | |
| 71271 | <1% | 123 | $14K | |
| 72114 | <1% | 284 | $14K | |
| 93017 | <1% | 252 | $14K | |
| 94664 | <1% | 1,234 | $13K | |
| 87632 | <1% | 95 | $13K | |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 43 | $13K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 407 | $13K |
| 85027 | <1% | 4,583 | $13K | |
| 82607 | <1% | 2,090 | $13K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 38 | $12K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,601 | $12K |
| 86706 | <1% | 2,814 | $11K | |
| 73565 | <1% | 674 | $11K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 441 | $10K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,941 | $10K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,427 | $10K |
| 83970 | <1% | 907 | $10K | |
| 70491 | <1% | 54 | $9K | |
| 74174 | <1% | 27 | $9K | |
| 82553 | <1% | 886 | $9K | |
| 97014 | <1% | 693 | $9K | |
| J2704 | Injection, propofol, 10 mg | <1% | 335 | $9K |
| 95816 | <1% | 95 | $9K | |
| 97010 | <1% | 734 | $8K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,082 | $8K |
| 0636 | <1% | 963 | $8K | |
| 88304 | <1% | 307 | $8K | |
| 72128 | <1% | 54 | $7K | |
| 86705 | <1% | 1,344 | $7K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 488 | $7K |
| 83550 | <1% | 2,269 | $7K | |
| 81002 | <1% | 3,190 | $7K | |
| 98966 | <1% | 625 | $7K | |
| 84100 | <1% | 1,803 | $7K | |
| J1815 | Injection, insulin, per 5 units | <1% | 717 | $6K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 360 | $6K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 49 | $6K |
| 73020 | <1% | 409 | $6K | |
| 82150 | <1% | 885 | $6K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 948 | $6K |
| 86255 | <1% | 779 | $6K | |
| 86704 | <1% | 1,180 | $6K | |
| 93793 | <1% | 394 | $6K | |
| 92582 | <1% | 120 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 11,122 | $5K |
| 93226 | <1% | 113 | $5K | |
| 99283 | Emergency room visit (moderate) | <1% | 294 | $5K |
| 97139 | <1% | 211 | $5K | |
| 84481 | <1% | 586 | $5K | |
| 12002 | <1% | 296 | $5K | |
| 99242 | <1% | 65 | $5K | |
| 99000 | <1% | 1,600 | $4K | |
| 12001 | <1% | 276 | $4K | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 148 | $4K |
| 86235 | <1% | 628 | $4K | |
| 82805 | <1% | 146 | $4K | |
| 82746 | <1% | 534 | $4K | |
| 36000 | <1% | 798 | $4K | |
| 93225 | <1% | 111 | $4K | |
| 72110 | <1% | 98 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 132 | $4K |
| 80076 | <1% | 849 | $4K | |
| Z7506 | <1% | 261 | $4K | |
| 87081 | <1% | 691 | $3K | |
| 87147 | <1% | 810 | $3K | |
| 83615 | <1% | 592 | $3K | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 133 | $3K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 111 | $3K |
| 92551 | <1% | 218 | $3K | |
| 87210 | <1% | 672 | $3K | |
| 82565 | <1% | 952 | $3K | |
| 86708 | <1% | 607 | $3K | |
| 82009 | <1% | 566 | $3K | |
| 87807 | <1% | 236 | $3K | |
| Q3014 | Telehealth originating site facility fee | <1% | 94 | $3K |
| 82946 | <1% | 149 | $3K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 101 | $2K |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 226 | $2K |
| 83721 | <1% | 1,906 | $2K | |
| 84520 | <1% | 1,930 | $2K | |
| 87400 | <1% | 292 | $2K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 25 | $2K |
| 97035 | <1% | 248 | $2K | |
| 36600 | <1% | 285 | $2K | |
| 97032 | <1% | 206 | $2K | |
| 82951 | <1% | 133 | $2K | |
| 77062 | <1% | 15 | $2K | |
| 97116 | <1% | 114 | $2K | |
| 76000 | <1% | 94 | $2K | |
| 74022 | <1% | 54 | $2K | |
| 81015 | <1% | 782 | $2K | |
| 73700 | <1% | 12 | $2K | |
| 84550 | <1% | 763 | $2K | |
| Z7504 | <1% | 32 | $2K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 54 | $2K |
| 87205 | <1% | 580 | $2K | |
| 82043 | <1% | 2,194 | $2K | |
| 12011 | <1% | 53 | $1K | |
| 76881 | <1% | 20 | $1K | |
| 29700 | <1% | 50 | $1K | |
| 77065 | Tomosynthesis, mammo | <1% | 13 | $1K |
| 86762 | <1% | 185 | $1K | |
| 86709 | <1% | 441 | $1K | |
| 97161 | <1% | 30 | $1K | |
| 73521 | <1% | 43 | $1K | |
| 10060 | <1% | 66 | $1K | |
| 94760 | <1% | 186 | $1K | |
| 29075 | <1% | 18 | $1K | |
| 83540 | <1% | 1,212 | $1K | |
| 86430 | <1% | 418 | $1K | |
| Z4300 | <1% | 12 | $1K | |
| 97018 | <1% | 106 | $1K | |
| 86787 | <1% | 158 | $1K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 71 | $1K |
| 86160 | <1% | 412 | $1K | |
| 31575 | <1% | 12 | $1K | |
| 82570 | <1% | 464 | $949.81 | |
| 90656 | <1% | 103 | $944.00 | |
| 82140 | <1% | 68 | $939.91 | |
| 86038 | <1% | 88 | $907.57 | |
| 73000 | <1% | 54 | $892.93 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 53 | $880.46 |
| 93308 | <1% | 24 | $821.49 | |
| G0378 | Hospital observation service, per hour | <1% | 341 | $765.77 |
| 72081 | <1% | 27 | $762.72 | |
| 90480 | <1% | 19 | $760.00 | |
| 29125 | <1% | 79 | $750.55 | |
| 72072 | <1% | 26 | $749.78 | |
| 74019 | <1% | 27 | $691.65 | |
| 87521 | Neg quan hep c or qual rna | <1% | 120 | $671.29 |
| 86225 | <1% | 456 | $633.90 | |
| 99285 | Emergency room visit (most serious) | <1% | 346 | $633.86 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 46 | $593.19 |
| 88313 | <1% | 14 | $575.68 | |
| 93299 | <1% | 28 | $558.54 | |
| 99188 | <1% | 27 | $481.68 | |
| 92591 | <1% | 13 | $481.02 | |
| 93242 | <1% | 24 | $437.76 | |
| 84703 | <1% | 52 | $437.21 | |
| 92579 | <1% | 13 | $425.14 | |
| 86592 | <1% | 289 | $421.57 | |
| 99201 | <1% | 12 | $412.20 | |
| 77080 | <1% | 12 | $406.44 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 148 | $371.71 |
| 85045 | <1% | 242 | $329.21 | |
| 82247 | <1% | 159 | $305.74 | |
| 84156 | <1% | 146 | $299.52 | |
| 83655 | <1% | 28 | $285.88 | |
| 87522 | Neg quan hep c or qual rna | <1% | 134 | $263.04 |
| 93246 | <1% | 14 | $237.12 | |
| 72200 | <1% | 12 | $230.42 | |
| 84153 | <1% | 139 | $225.76 | |
| 87338 | <1% | 287 | $217.10 | |
| 84466 | <1% | 180 | $214.78 | |
| 87045 | <1% | 58 | $212.92 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 26 | $196.04 |
| 83930 | <1% | 26 | $185.54 | |
| D1206 | Topical application of fluoride varnish | <1% | 13 | $180.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 29 | $159.61 |
| 86039 | <1% | 27 | $153.26 | |
| 84403 | <1% | 54 | $147.80 | |
| 90677 | <1% | 12 | $108.00 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 159 | $107.75 |
| 85007 | <1% | 40 | $107.14 | |
| 87427 | <1% | 12 | $105.85 | |
| 86593 | <1% | 77 | $101.43 | |
| 85018 | <1% | 30 | $100.50 | |
| 29105 | <1% | 12 | $93.60 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 13 | $83.57 |
| 87075 | <1% | 25 | $74.00 | |
| 82378 | <1% | 14 | $72.00 | |
| 99173 | <1% | 14 | $66.85 | |
| 82105 | <1% | 12 | $57.76 | |
| 82274 | <1% | 51 | $57.15 | |
| 82310 | <1% | 96 | $49.20 | |
| 82040 | <1% | 73 | $49.02 | |
| 80164 | <1% | 12 | $43.98 | |
| 84154 | <1% | 25 | $22.00 | |
| 84270 | <1% | 30 | $20.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 44 | $18.03 |
| 36415 | Collection of venous blood by venipuncture | <1% | 645 | $16.43 |
| 83520 | <1% | 56 | $12.29 | |
| 86200 | <1% | 215 | $8.52 | |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 406 | $4.60 |
| 84155 | <1% | 174 | $1.98 | |
| J0606 | Injection, etelcalcetide, 0.1 mg | 0% | 569 | $0.00 |
| 00250 | 0% | 38 | $0.00 | |
| 84075 | 0% | 169 | $0.00 | |
| 87536 | 0% | 13 | $0.00 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 233 | $0.00 |
| 82172 | 0% | 42 | $0.00 | |
| 29705 | 0% | 14 | $0.00 | |
| 86147 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKAPRE, SHEELA (CHIEF MEDICAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| San Joaquin Faculty Medical Group | French Camp, CA | $12.01M |
| County of San Joaquin | French Camp, CA | $11.15M |
| County of San Joaquin | French Camp, CA | $11.04M |
| County of San Joaquin | French Camp, CA | $202K |
| County of San Joaquin | French Camp, CA | $3K |
| County of San Joaquin | French Camp, CA | $262.02 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.